CD4 and neoplasm: Compared with the CLDN18.2-mBBZ CAR-T group, the FAP-mBBZ CAR-T group showed more CD8+ T cells in tumor tissue, whereas the CD4+ T cells in each group showed no differences (Fig. 6d, g).